Home › NCT06640010

Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Any patient \>= 18 years of age
* Previously treated, planned or currently receiving any potentially toxic cancer therapy including but not limited to chemotherapy, targeted and immunotherapies

Exclusion Criteria:

* Inability on the part of the patient to understand the informed consent or be compliant with the protocol

About the study

This study is being done to find out if patient blood samples can be used to perform individualized modeling of cancer therapy-related side effects.

What is being tested

• Non-Interventional Study (other)

Sponsor: Mayo Clinic · Participants: 30 · Started: Feb 12, 2025

Contact the study team

• Clinical Trials Referral Office · Phone: 855-776-0015

Official record on ClinicalTrials.gov — NCT06640010

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.